U.S. federal trademark · Serial No. 78160140
Pharmaceutical preparations; antibody preparations; monoclonal antibodies; biological preparations; biological cultures; cell cultures; cell lines; chemical preparations; cultures of micro organisms; diagnostic preparations; enzymes; genes; proteins; recombinant antibodies; vaccines; all of the above aforesaid goods being for the diagnosis or treatment of amyloidosis.
Scientific, medical and industrial research, all relating to amyloidosis; biochemical analysis and biochemical research both relating to amyloidosis; diagnosis of predisposition to amyloidosis; amyloidosis disease management; amyloidosis drug design; amyloidosis health care; prophylaxis and treatment of medical disorders all relating to amyloidosis; vaccination and treatment of amyloidosis patients.
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.